David E. Kleiner
Impact in
- Hepatology top 0.01%
- Hepatitis C virus research
- Liver Disease and Transplantation
- Liver Diseases and Immunity
- Epidemiology top 0.01%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
Papers in
- Epidemiology 207
- Liver Disease Diagnosis and Treatment 161
- Hepatitis B Virus Studies 51
- Hepatology 115
- Hepatitis C virus research 60
- Liver Disease and Transplantation 28
- Liver Diseases and Immunity 23
- Hepatocellular Carcinoma Treatment and Prognosis 17
- Co-authors
- Elizabeth M. Brunt (27 shared papers)Arun J. Sanyal (33 shared papers)William G. Stetler‐Stevenson (17 shared papers)Mark L. Van Natta (17 shared papers)Arthur J. McCullough (8 shared papers)Brent A. Neuschwander‐Tetri (31 shared papers)Jay H. Hoofnagle (74 shared papers)Cynthia Behling (13 shared papers)
- Journals
- Hepatology (62 papers)Gastroenterology (33 papers)Alimentary Pharmacology & Therapeutics (21 papers)Clinical Gastroenterology and Hepatology (21 papers)Journal of Hepatology (19 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
David E. Kleiner
503 papers receiving 50.6k citations
David E. Kleiner's Hit Papers
Peers
Comparison fields: 5 of 178
- Hepatology 11.6k
- Epidemiology 27.6k
- Transplantation 1.2k
- Endocrinology, Diabetes and Metabolism 7.2k
- Pharmacology 2.6k
Countries citing papers authored by David E. Kleiner
This map shows the geographic impact of David E. Kleiner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Kleiner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Kleiner more than expected).
Fields of papers citing papers by David E. Kleiner
This network shows the impact of papers produced by David E. Kleiner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Kleiner. The network helps show where David E. Kleiner may publish in the future.
Co-authors
The 25 scholars most cited alongside David E. Kleiner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 522 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Design and validation of a histological scoring system for nonalcoholic fatty liver disease† Hit paper breakdown → | 2005 | 8495 |
| 2 | Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis Hit paper breakdown → | 2010 | 2502 |
| 3 | Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease Hit paper breakdown → | 2015 | 2173 |
| 4 | Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial Hit paper breakdown → | 2014 | 1758 |
| 5 | AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease Hit paper breakdown → | 2023 | 1326 |
| 6 | Randomized Controlled Trial Testing the Effects of Weight Loss on Nonalcoholic Steatohepatitis Hit paper breakdown → | 2009 | 1011 |
| 7 | Nonalcoholic Fatty Liver Disease (NAFLD) Activity Score and the Histopathologic Diagnosis in NAFLD: Distinct Clinicopathologic Meanings §Δ Hit paper breakdown → | 2010 | 946 |
| 8 | Quantitative Zymography: Detection of Picogram Quantities of Gelatinases Hit paper breakdown → | 1994 | 773 |
| 9 | Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease Hit paper breakdown → | 2021 | 699 |
| 10 | Enterocolitis in Patients With Cancer After Antibody Blockade of Cytotoxic T-Lymphocyte–Associated Antigen 4 Hit paper breakdown → | 2006 | 645 |
| 11 | Matrix metalloproteinases and metastasis Hit paper breakdown → | 1999 | 602 |
| 12 | Endpoints and clinical trial design for nonalcoholic steatohepatitis Hit paper breakdown → | 2011 | 590 |
| 13 | A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis† ‡ Hit paper breakdown → | 2004 | 588 |
| 14 | NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis Hit paper breakdown → | 2016 | 582 |
| 15 | Tumor Cell Biodiversity Drives Microenvironmental Reprogramming in Liver Cancer Hit paper breakdown → | 2019 | 536 |
| 16 | Extracellular matrix 6: Role of matrix metalloproteinases in tumor invasion and metastasis Hit paper breakdown → | 1993 | 520 |
| 17 | Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease Hit paper breakdown → | 2018 | 466 |
| 18 | 1995 | 442 | |
| 19 | 2005 | 381 | |
| 20 | 2020 | 381 |
About David E. Kleiner
David E. Kleiner is a scholar working on Epidemiology, Hepatology, Oncology, Pharmacology and Surgery, having authored 522 papers that have together received 51.6k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (161 papers), Hepatitis C virus research (60 papers), Drug-Induced Hepatotoxicity and Protection (59 papers), Hepatitis B Virus Studies (51 papers), Liver Disease and Transplantation (28 papers), Liver Diseases and Immunity (23 papers), Hepatocellular Carcinoma Treatment and Prognosis (17 papers) and Cancer Immunotherapy and Biomarkers (15 papers). The work is most often cited by research in Hepatology (11.6k citations), Epidemiology (27.6k citations), Transplantation (1.2k citations), Endocrinology, Diabetes and Metabolism (7.2k citations) and Pharmacology (2.6k citations). David E. Kleiner has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Elizabeth M. Brunt, Arun J. Sanyal, William G. Stetler‐Stevenson, Mark L. Van Natta, Arthur J. McCullough, Brent A. Neuschwander‐Tetri, Jay H. Hoofnagle, Cynthia Behling, Aynur Ünalp–Arida and Oscar W. Cummings. Their work appears in journals such as Hepatology, Gastroenterology, Alimentary Pharmacology & Therapeutics, Clinical Gastroenterology and Hepatology and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.